{"id":115,"date":"2025-01-12T12:32:00","date_gmt":"2025-01-12T12:32:00","guid":{"rendered":"https:\/\/aerodreamsbd.com\/marcelstadler\/?p=115"},"modified":"2025-05-19T09:43:21","modified_gmt":"2025-05-19T09:43:21","slug":"prime-proteins-and-lysando","status":"publish","type":"post","link":"https:\/\/aerodreamsbd.com\/marcelstadler\/news\/prime-proteins-and-lysando\/","title":{"rendered":"Prime Proteins and Lysando: AI-Driven Protein Design for Enhanced Bacterial Combat"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tIn the relentless battle against multiresistant pathogenic bacteria, Lysando Innovations Lab GmbH stands at the forefront with groundbreaking advancements in protein design technology. Leveraging the power of \u200bPRIME Proteins’s machine learning methods<\/strong>, Lysando has recently achieved significant improvements in enhancing the thermostability and production efficiency of their antimicrobial proteins (Artiylisins).\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Who Is Lysando?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tLysando is the leading company in designing recombinant antimicrobial molecules. With a database that contains over 4,000 constructs, artificial intelligence-based services strongly support Lysando\u00b4s development work.\n\u200bPRIME Proteins <\/strong> is Lysando\u2019s long-term partner for state-of-the-art technology in artificial intelligence methods, and due to a great partnership, Lysando not only saves time and costs but also gains additional IP.\n\nLast but not least, apart from this excellent cooperation, the IT security provided by Prime IT AI is mandatory, and together, we are constantly on the run to introduce new technology and optimize current methods. \t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

The AI Revolution in Protein Design<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tThe integration of AI into protein design has marked a new era in biotechnology. Traditionally, designing proteins that could effectively combat bacterial pathogens involved extensive trial and error, limited by the natural instability of proteins at higher temperatures and the complexities of large-scale production. However,\u00a0
PRIME Proteins’s recent technologies in AI have transformed this landscape.\u00a0<\/strong>By employing machine learning algorithms, companies are finally able to predict and engineer protein sequences with unprecedented precision and unmatched speed, mainly focusing on two critical aspects: thermostability and production yield.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Looking forward<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tLysando Innovations Lab GmbH’s journey into AI-driven protein design exemplifies the fusion of technology with biology, aiming not just to treat but to revolutionize how we combat bacterial infections. As these technologies mature, we might see a future where personalized medicine, based on individual microbial profiles, becomes a reality, thanks to the precision and scalability offered by AI in protein design.
\u200bThis advancement by Lysando not only showcases the potential of AI in biotechnology but also underscores a hopeful narrative in our ongoing fight against microbial adversaries. With continued research and development, Lysando is contributing significantly to a future where infectious diseases might be managed with greater ease and effectiveness.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard…..<\/p>\n","protected":false},"author":1,"featured_media":117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-115","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/aerodreamsbd.com\/marcelstadler\/wp-json\/wp\/v2\/posts\/115","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aerodreamsbd.com\/marcelstadler\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aerodreamsbd.com\/marcelstadler\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aerodreamsbd.com\/marcelstadler\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aerodreamsbd.com\/marcelstadler\/wp-json\/wp\/v2\/comments?post=115"}],"version-history":[{"count":13,"href":"https:\/\/aerodreamsbd.com\/marcelstadler\/wp-json\/wp\/v2\/posts\/115\/revisions"}],"predecessor-version":[{"id":865,"href":"https:\/\/aerodreamsbd.com\/marcelstadler\/wp-json\/wp\/v2\/posts\/115\/revisions\/865"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aerodreamsbd.com\/marcelstadler\/wp-json\/wp\/v2\/media\/117"}],"wp:attachment":[{"href":"https:\/\/aerodreamsbd.com\/marcelstadler\/wp-json\/wp\/v2\/media?parent=115"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aerodreamsbd.com\/marcelstadler\/wp-json\/wp\/v2\/categories?post=115"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aerodreamsbd.com\/marcelstadler\/wp-json\/wp\/v2\/tags?post=115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}